This content is for subscribers only. Please click here to see our plans.

biotech analyst roundup Biotech Analyst Roundup: Telix, Q32 Bio, Nurix, AVITA Medical, Halozyme, PTC Therapeutics & Prelude Therapeutics Biotech Analyst Sentiment at a Glance The latest analyst commentary across the biotech and specialty-pharma universe shows a wide divergence in risk/reward profiles. Several companies are benefiting from major clinical, regulatory or partnership catalysts, while others face valuation concerns after substantial stock…

biotech & health insights 💊 StockInsight™ Pharma Earnings Roundup The 10 Biggest Pharmaceutical Earnings Reports So Far Q2 2026 Earnings Season | Industry Scorecard & Investor Outlook The second-quarter 2026 earnings season has reinforced one clear message: innovation remains the primary growth driver for the pharmaceutical industry. Companies with blockbuster launches in oncology, obesity, immunology, and HIV continue to outperform,…